Schedule 13G ownership disclosure
Day One Biopharmaceuticals Inc
Common Stock, par value $0.0001 per share · CUSIP: 23954D109
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 5,755,577.00 · Class: 5.7%
- Peter Kolchinsky
Shares: 5,755,577.00 · Class: 5.7%
- Rajeev Shah
Shares: 5,755,577.00 · Class: 5.7%
- RA Capital Healthcare Fund, L.P.
Shares: 5,307,848.00 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-004277
- Form type
- SCHEDULE 13G/A
- Filer
- Day One Biopharmaceuticals, Inc.
- CIK
- CIK 1845337
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership